Cargando…
A five‐miRNA panel in plasma was identified for breast cancer diagnosis
Breast cancer (BC) is one of the most common cancers in females. Since early detection can bring prognosis benefit, discovery of novel noninvasive biomarkers for BC diagnosis is in urgent need. In this four‐phase study, we profiled miRNA expression in plasma samples from a total of 257 BC patients a...
Autores principales: | Li, Minghui, Zou, Xuan, Xia, Tiansong, Wang, Tongshan, Liu, Ping, Zhou, Xin, Wang, Shui, Zhu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853814/ https://www.ncbi.nlm.nih.gov/pubmed/31568692 http://dx.doi.org/10.1002/cam4.2572 |
Ejemplares similares
-
Identification of a six‐miRNA panel in serum benefiting pancreatic cancer diagnosis
por: Zou, Xuan, et al.
Publicado: (2019) -
Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China
por: Shan, Xia, et al.
Publicado: (2018) -
Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer
por: Ma, Ge, et al.
Publicado: (2020) -
Identification of a 7‐microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection
por: Zhang, Huo, et al.
Publicado: (2019) -
Plasma miRNA can detect colorectal cancer, but how early?
por: Wikberg, Maria L., et al.
Publicado: (2018)